How long does it take to take Fenelidone/Cashenda before you can consider stopping the drug?

Finerenone is a selective mineralocorticoid receptor antagonist (MRA) used to treat patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). The drug's mechanism of action is mainly by antagonizing mineralocorticoid receptors, thereby reducing sodium and water retention, reducing the burden on the kidneys and cardiovascular system, and helping to improve the patient's condition.

There is currently no unified standard answer to the question of discontinuation of fenelidone. Usually, fenelidone is a long-term treatment drug and usually needs to be taken for a long time to achieve its best effect. Whether and when to discontinue medication usually depends on factors such as the patient's response to treatment, the stability of the condition, and the occurrence of side effects.

1. Factors of treatment time: The treatment time of fenelidone should be adjusted according to the patient's condition. After initiating treatment, the effects of the drug usually need to be evaluated and a decision made whether to continue or discontinue the drug based on the patient's clinical response. Generally speaking, patients should undergo long-term treatment under the guidance of a doctor, especially in CKD and T2D patients, whose condition may change over time.

2. Disease control and stability: For those patients whose condition is stable and whose renal function has improved, it may be considered to reduce the frequency of drug use or gradually discontinue the drug. However, renal function in patients with CKD will continue to decline to a certain extent, so the decision to discontinue medication should be made with caution. Generally, discontinuation of the drug is considered only after long-term monitoring and when the patient's eGFR (estimated tubular filtration rate) is stable and has not worsened.

3. Effects of side effects: Side effects of fenelinone may include hyperkalemia (especially common in elderly patients). Therefore, patients need to regularly monitor serum potassium levels while taking the drug. If serious side effects occur, especially if the risk of hyperkalemia is greater, your doctor may decide to stop the medication and adjust your treatment plan.

Keyword tags: Finerenone,Finerenone, discontinuation, CKD, T2D, treatment time, side effects, hyperkalemia, drug adjustment

Reference materials:https://www.kerendia.com/